Evidence map›Paper›PMID 35891697›Full record

ArticleOpen forum infectious diseases2022

Different Clinical Presentations of Human Rhinovirus Species Infection in Children and Adults in Mexico.

Arturo Galindo-Fraga, Paola Del Carmen Guerra-de-Blas, Ana M Ortega-Villa, Allyson Mateja, Jesus Arturo Ruiz Quiñones, Pilar Ramos Cervantes, Fernando Ledesma Barrientos, Ana A Ortiz-Hernández, Beatriz Llamosas-Gallardo, Alejandra Ramírez-Venegas and 8 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 2 countries.

Arturo Galindo-FragaDepartamento de Epidemiología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-2818-1160
Paola Del Carmen Guerra-de-BlasMexican Emerging Infectious Diseases Clinical Research Network, Mexico City, Mexico.ORCID https://orcid.org/0000-0003-3050-6865
Ana M Ortega-VillaNational Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
Allyson MatejaClinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Jesus Arturo Ruiz QuiñonesDepartamento de Epidemiología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Pilar Ramos CervantesDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Fernando Ledesma BarrientosDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Ana A Ortiz-HernándezDivisión de Desarrollo y Enlace Interinstitucional, Instituto Nacional de Pediatría, Mexico City, Mexico.
Beatriz Llamosas-GallardoDivisión de Desarrollo y Enlace Interinstitucional, Instituto Nacional de Pediatría, Mexico City, Mexico.
Alejandra Ramírez-VenegasDepartamento de Investigación en Tabaquismo y en Enfermedades Pulmonares Obstructivas Crónicas, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Mexico City, Mexico.
Rafael Valdéz VázquezDepartamento de Infectología, Hospital General "Dr Manuel Gea González," Mexico City, Mexico.
Daniel Noyola ChepitelMicrobiology Department, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí, Mexico.
Sarbelio Moreno-EspinosaDepartamento de Infectología, Hospital Infantil de México Federico Gómez, Instituto Nacional de Salud, Mexico City, Mexico.
John H PowersClinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
M Lourdes GuerreroDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Guillermo M Ruiz-PalaciosDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
John H BeigelNational Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.ORCID https://orcid.org/0000-0002-4879-4941
Mexican Emerging Infectious Diseases Network
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXFrederick National Laboratory for Cancer Research · USInstituto Nacional de Pediatria · MXNational Institute of Allergy and Infectious Diseases · USAutonomous University of San Luis Potosí · MXHospital General Dr. Manuel Gea Gonzalez · MXHospital Infantil de México Federico Gómez · MXInstituto Nacional de Enfermedades Respiratorias · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Human rhinoviruses (HRVs) are a common cause of influenza-like illness, with the ability to infect the upper and lower respiratory tracts. In this study we aim to describe the clinical and molecular features of HRV infection in Mexican children and adults. Methods: We performed a hospital-based, 4-year multicenter prospective observational cohort study of patients with influenza-like illness. Participants who tested positive for HRV were included. We described demographic, clinical, and laboratory characteristics and the association between HRV types, illness severity, and clinical outcomes. Results: Of the 5662 subjects recruited, 1473 (26%) had HRV; of those, 988 (67.1%) were adults (≥18 years) and 485 (32.9%) were children. One hundred sixty-seven (11.33%) samples were sequenced; 101 (60.5%) were rhinovirus species A (HRV-A), 22 (13.2%) were rhinovirus species B (HRV-B), and 44 (26.3%) were rhinovirus species C (HRV-C). Among children and adults, 30.5% and 23.5%, respectively, were hospitalized (non-intensive care unit [ICU]). The odds of HRV-C are higher than HRV-A for participants in the ICU (compared to outpatient) and when platelets, lymphocytes, white blood cells, and lactate dehydrogenase are increased. The odds of HRV-C are higher than HRV-A and HRV-B with shortness of breath. The odds of HRV-A are higher than HRV-B, and the odds of HRV-B are higher than HRV-C, when mild symptoms like muscle ache and headache occur. Conclusions: Rhinoviruses are a common cause of influenza-like illness. It is necessary to improve the surveillance, testing, and species identification for these viruses to understand different clinical presentations and risk factors associated with worse outcomes.

Indexed as

clinical presentationHRV speciesinfluenza-like illnessrhinovirusseverity

Identifiers

PMID35891697
PMCPMC9308452
OpenAlexW4283012012

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.